Home » Topics » Regulatory » Patents

Patents
RSS

Bristol-Myers Squibb divulgues myeloperoxidase and/or eosinophil peroxidase inhibitors

March 23, 2017

Shenzhen Qingyaqirui Bio-Tech identifies new conjugates of memantine and arctigenin

March 23, 2017

Bayer Pharma discovers coagulation factor XIa and kallikrein inhibitors

March 23, 2017

Eli Lilly and Company discloses new histone-lysine N-methyltransferase EZH2 inhibitors

March 23, 2017

Achillion Pharmaceuticals patents complement factor D inhibitors

March 23, 2017

Lysosomal Therapeutics discovers novel glucosylceramidase activators

March 22, 2017

The University of Arizona divulges novel DYRK1A inhibitors

March 22, 2017

Takeda presents new toll-like receptor inhibitors

March 22, 2017

Bristol-Myers Squibb describes novel TGF-beta receptor antagonists

March 22, 2017

Alla Chem patents hepatitis C virus NS5A inhibitors

March 22, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....